Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (656)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
301
12.180
 Why?
Ovarian Neoplasms
38
2025
459
2.810
 Why?
Papillomavirus Infections
19
2025
177
2.760
 Why?
Endometrial Neoplasms
34
2019
143
2.250
 Why?
Uterine Cervical Dysplasia
16
2017
51
2.230
 Why?
Carcinoma, Squamous Cell
31
2018
332
1.900
 Why?
Gene Expression Regulation, Neoplastic
19
2025
868
1.800
 Why?
Human papillomavirus 16
8
2019
44
1.610
 Why?
Papillomaviridae
17
2025
104
1.510
 Why?
Female
193
2026
28782
1.480
 Why?
Gene Expression Profiling
9
2021
1112
1.420
 Why?
Antineoplastic Combined Chemotherapy Protocols
18
2025
1043
1.360
 Why?
DNA Methylation
22
2025
592
1.240
 Why?
Genital Neoplasms, Female
10
2018
48
1.110
 Why?
Humans
196
2026
53230
1.100
 Why?
Human papillomavirus 18
5
2019
9
1.090
 Why?
Genetic Predisposition to Disease
14
2024
533
1.050
 Why?
Adult
92
2024
14534
1.000
 Why?
Neoplasm Staging
41
2019
774
0.970
 Why?
Middle Aged
99
2024
13419
0.940
 Why?
Adenocarcinoma
18
2018
405
0.940
 Why?
Polymorphism, Single Nucleotide
10
2019
505
0.900
 Why?
Fluorodeoxyglucose F18
15
2022
182
0.890
 Why?
DNA-Binding Proteins
9
2021
423
0.880
 Why?
Neoplasm Recurrence, Local
19
2024
647
0.870
 Why?
MicroRNAs
7
2019
397
0.860
 Why?
Carcinoma
12
2010
136
0.850
 Why?
Genomics
5
2026
271
0.800
 Why?
Oncogene Proteins, Viral
4
2019
52
0.790
 Why?
Radiopharmaceuticals
14
2022
198
0.750
 Why?
Repressor Proteins
4
2019
149
0.750
 Why?
Cervix Uteri
7
2017
43
0.740
 Why?
Cell Line, Tumor
19
2025
1470
0.720
 Why?
Alphapapillomavirus
1
2021
14
0.700
 Why?
DNA, Viral
6
2019
136
0.690
 Why?
Granulosa Cell Tumor
3
2025
4
0.670
 Why?
Immunologic Factors
2
2014
117
0.670
 Why?
Neoplasm Invasiveness
15
2020
281
0.640
 Why?
Neoplasms
8
2022
1334
0.630
 Why?
Genetic Markers
8
2017
104
0.620
 Why?
Genes, Tumor Suppressor
8
2007
73
0.620
 Why?
Neoplasm Proteins
10
2019
330
0.620
 Why?
Immunoglobulins
3
2017
76
0.610
 Why?
Aged
70
2024
10429
0.600
 Why?
Gene Silencing
5
2018
122
0.570
 Why?
Biomedical Research
1
2022
267
0.570
 Why?
Vascular Endothelial Growth Factor A
2
2017
189
0.520
 Why?
Cisplatin
7
2022
282
0.510
 Why?
Proteomics
1
2019
336
0.510
 Why?
Promoter Regions, Genetic
12
2020
465
0.490
 Why?
Aged, 80 and over
36
2024
3494
0.490
 Why?
HLA-C Antigens
2
2018
5
0.480
 Why?
Receptors, KIR
2
2018
11
0.480
 Why?
Positron-Emission Tomography
11
2013
298
0.460
 Why?
Lymph Nodes
10
2010
252
0.460
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.460
 Why?
Tumor Virus Infections
4
2006
46
0.460
 Why?
Alleles
6
2025
277
0.460
 Why?
Microsatellite Repeats
14
2007
41
0.460
 Why?
Disease-Free Survival
17
2013
466
0.450
 Why?
Hysterectomy
15
2022
91
0.450
 Why?
Gynecologic Surgical Procedures
4
2010
29
0.450
 Why?
Virus Integration
3
2025
9
0.440
 Why?
Phenotype
5
2016
803
0.420
 Why?
Prognosis
19
2021
2118
0.420
 Why?
Lymphatic Metastasis
14
2019
211
0.410
 Why?
Immunohistochemistry
13
2024
975
0.410
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.410
 Why?
Nuclear Proteins
8
2009
250
0.400
 Why?
Loss of Heterozygosity
10
2007
78
0.400
 Why?
Cell Proliferation
7
2025
1031
0.390
 Why?
Ovary
2
2008
103
0.380
 Why?
Membrane Proteins
3
2005
333
0.380
 Why?
Genotype
9
2018
563
0.370
 Why?
Survival Analysis
14
2021
659
0.370
 Why?
STAT3 Transcription Factor
3
2021
89
0.360
 Why?
Cell Movement
5
2021
279
0.360
 Why?
Ultrasonic Therapy
3
2001
30
0.360
 Why?
Peritoneal Neoplasms
4
2008
68
0.350
 Why?
Carcinoma, Endometrioid
6
2014
38
0.350
 Why?
Genes, p53
2
2010
51
0.350
 Why?
Uterine Neoplasms
5
2009
57
0.330
 Why?
Risk Factors
13
2019
4017
0.330
 Why?
Signal Transduction
8
2021
1748
0.330
 Why?
Mutation
12
2018
1337
0.330
 Why?
Antibodies, Monoclonal
5
2021
477
0.330
 Why?
Ascites
2
2008
31
0.330
 Why?
Carboplatin
2
2009
57
0.330
 Why?
Antineoplastic Agents
9
2014
1232
0.320
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
11
0.320
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
15
0.320
 Why?
Cohort Studies
13
2024
1557
0.320
 Why?
Base Sequence
8
2019
620
0.320
 Why?
Membrane Glycoproteins
2
2009
238
0.310
 Why?
GTPase-Activating Proteins
1
2009
25
0.310
 Why?
Disease Progression
6
2020
880
0.310
 Why?
DNA, Neoplasm
11
2006
146
0.310
 Why?
Matrix Metalloproteinase 9
1
2009
88
0.300
 Why?
Chromosomes, Human, Pair 11
3
2005
56
0.300
 Why?
Neoplasms, Glandular and Epithelial
3
2006
42
0.300
 Why?
Brachytherapy
9
2014
51
0.300
 Why?
Combined Modality Therapy
11
2010
640
0.300
 Why?
Abdominal Neoplasms
1
2009
16
0.290
 Why?
Proto-Oncogene Proteins c-myc
2
2021
55
0.290
 Why?
Genome, Human
3
2025
121
0.290
 Why?
Laser Coagulation
1
2009
26
0.290
 Why?
DNA Repair
11
2007
197
0.290
 Why?
Drug Administration Schedule
10
2013
370
0.290
 Why?
Retrospective Studies
33
2024
6819
0.290
 Why?
Homeodomain Proteins
2
2006
81
0.280
 Why?
Deoxycytidine
4
2006
26
0.280
 Why?
RNA-Binding Proteins
2
2021
133
0.280
 Why?
Laparoscopy
3
2022
180
0.280
 Why?
Microsatellite Instability
5
2019
21
0.280
 Why?
Protozoan Proteins
1
2008
33
0.280
 Why?
Germ-Line Mutation
3
2024
67
0.280
 Why?
Kaplan-Meier Estimate
6
2019
487
0.270
 Why?
Ovariectomy
7
2010
114
0.270
 Why?
Antigens, CD
2
2007
217
0.260
 Why?
Breast Neoplasms
6
2026
1222
0.260
 Why?
Heart Arrest
1
2009
144
0.260
 Why?
Drug Resistance, Neoplasm
6
2016
350
0.260
 Why?
Polymerase Chain Reaction
9
2010
452
0.260
 Why?
Chromosomes, Human, Pair 3
4
2001
18
0.260
 Why?
SOXC Transcription Factors
2
2019
13
0.260
 Why?
Receptors, Estrogen
3
2024
134
0.250
 Why?
Topotecan
5
2013
17
0.250
 Why?
POU Domain Factors
1
2006
1
0.250
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.240
 Why?
Vulvar Neoplasms
5
2002
61
0.240
 Why?
Neoplasm Metastasis
5
2021
237
0.240
 Why?
HeLa Cells
3
2021
243
0.240
 Why?
Genome, Viral
2
2025
78
0.230
 Why?
Registries
6
2010
652
0.230
 Why?
Anemia
3
2020
76
0.230
 Why?
Survival Rate
10
2009
949
0.230
 Why?
Antineoplastic Agents, Hormonal
1
2025
56
0.230
 Why?
Vaginal Smears
6
2006
28
0.230
 Why?
Breast
1
2026
87
0.230
 Why?
Young Adult
7
2018
4511
0.230
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
579
0.220
 Why?
Gene Rearrangement
1
2025
76
0.220
 Why?
Chromosome Aberrations
1
2006
297
0.220
 Why?
HSP70 Heat-Shock Proteins
1
2004
71
0.210
 Why?
Receptors, Androgen
1
2024
48
0.210
 Why?
Receptors, Progesterone
1
2024
68
0.210
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.200
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.200
 Why?
Oncostatin M
2
2021
5
0.200
 Why?
Quinazolines
1
2003
34
0.200
 Why?
Antigens, Neoplasm
1
2004
146
0.200
 Why?
Polymorphism, Genetic
5
2018
181
0.200
 Why?
Genome-Wide Association Study
2
2017
184
0.200
 Why?
Small Cell Lung Carcinoma
1
2023
30
0.190
 Why?
Omentum
1
2002
16
0.190
 Why?
Case-Control Studies
7
2019
1212
0.190
 Why?
Chromosome Deletion
3
2000
138
0.190
 Why?
Treatment Outcome
23
2014
5595
0.190
 Why?
Neoadjuvant Therapy
2
2022
124
0.180
 Why?
Linkage Disequilibrium
3
2017
41
0.180
 Why?
Proto-Oncogene Proteins c-akt
2
2014
171
0.180
 Why?
Genetic Variation
4
2019
223
0.180
 Why?
Antibodies, Monoclonal, Humanized
5
2013
238
0.180
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.180
 Why?
CA-125 Antigen
3
2008
16
0.180
 Why?
Base Pair Mismatch
5
2006
20
0.180
 Why?
Suction
1
2001
22
0.180
 Why?
Chemoradiotherapy
1
2022
50
0.180
 Why?
Tumor Microenvironment
2
2021
274
0.180
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.180
 Why?
Postoperative Complications
3
2022
1099
0.180
 Why?
Smoking
1
2005
526
0.180
 Why?
Proteins
5
2008
351
0.170
 Why?
Radiotherapy, Conformal
2
2014
51
0.170
 Why?
Carcinoma in Situ
2
2013
72
0.170
 Why?
Adaptor Proteins, Signal Transducing
8
2007
202
0.170
 Why?
Antimetabolites, Antineoplastic
2
2002
39
0.170
 Why?
Minority Groups
1
2022
136
0.170
 Why?
Radiotherapy
3
2010
126
0.170
 Why?
Gene Regulatory Networks
2
2019
112
0.170
 Why?
Fetofetal Transfusion
1
2020
5
0.170
 Why?
Pregnancy, Twin
1
2020
7
0.170
 Why?
Polycythemia
1
2020
10
0.170
 Why?
Twins, Monozygotic
1
2020
15
0.170
 Why?
Lymph Node Excision
7
2019
132
0.160
 Why?
Colorectal Neoplasms
3
2002
302
0.160
 Why?
Sarcoma
3
2009
72
0.160
 Why?
Genetic Diseases, Inborn
1
2000
23
0.160
 Why?
Patient Satisfaction
2
2006
292
0.160
 Why?
Receptor, erbB-3
1
2020
2
0.160
 Why?
Furin
1
2020
3
0.160
 Why?
Phosphoproteins
2
2016
117
0.160
 Why?
HLA-DQ Antigens
1
2000
3
0.160
 Why?
Receptor, IGF Type 1
1
2020
21
0.160
 Why?
Transcriptome
2
2020
367
0.160
 Why?
Mice, Nude
4
2021
232
0.160
 Why?
Tomography, X-Ray Computed
7
2013
1180
0.160
 Why?
Prenatal Diagnosis
1
2020
94
0.160
 Why?
Tumor Cells, Cultured
7
2021
441
0.160
 Why?
RNA, Neoplasm
3
2007
45
0.150
 Why?
Antibodies, Neoplasm
1
2019
27
0.150
 Why?
Students
1
2022
249
0.150
 Why?
Papillomavirus E7 Proteins
2
2017
30
0.150
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.150
 Why?
Reproducibility of Results
2
2022
1219
0.150
 Why?
Adolescent
13
2018
6907
0.150
 Why?
Placenta
1
2020
146
0.150
 Why?
Follow-Up Studies
13
2019
2318
0.140
 Why?
Indocyanine Green
1
2019
29
0.140
 Why?
Doxorubicin
4
2009
247
0.140
 Why?
Fallopian Tube Neoplasms
3
2008
15
0.140
 Why?
Decision Making
1
2001
278
0.140
 Why?
Salvage Therapy
3
2008
138
0.140
 Why?
Cyclooxygenase 2
2
2017
49
0.140
 Why?
Sequence Analysis, DNA
1
2019
216
0.140
 Why?
Transcription Factors
1
2021
571
0.140
 Why?
HLA-DRB1 Chains
1
2017
6
0.130
 Why?
Metabolic Networks and Pathways
1
2018
90
0.130
 Why?
HLA-B Antigens
1
2017
8
0.130
 Why?
Lung Neoplasms
2
2023
645
0.130
 Why?
DNA Copy Number Variations
1
2018
117
0.130
 Why?
Proto-Oncogene Proteins
5
2004
150
0.130
 Why?
Receptors, Vitronectin
1
1997
1
0.130
 Why?
Tumor Suppressor Proteins
3
2005
130
0.130
 Why?
Carcinoma, Adenosquamous
3
2009
9
0.130
 Why?
DNA Mutational Analysis
9
2005
179
0.130
 Why?
Interleukin-10
1
2017
81
0.130
 Why?
Bayes Theorem
1
2017
120
0.130
 Why?
Animals
11
2021
13526
0.130
 Why?
Leukocytes, Mononuclear
1
2017
122
0.130
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
22
0.130
 Why?
In Situ Hybridization
3
2008
69
0.130
 Why?
Protein Binding
1
2019
670
0.130
 Why?
Radiotherapy, Intensity-Modulated
2
2009
181
0.130
 Why?
Adipose Tissue
1
2019
210
0.130
 Why?
Gene Expression Regulation, Viral
1
2017
49
0.130
 Why?
Risk Assessment
9
2019
1368
0.120
 Why?
Radiotherapy Dosage
8
2014
249
0.120
 Why?
Body Mass Index
3
2010
717
0.120
 Why?
Diagnosis, Differential
4
2024
1038
0.120
 Why?
Radiation Injuries
3
2008
114
0.120
 Why?
ROC Curve
1
2017
246
0.120
 Why?
Taxoids
3
2006
38
0.120
 Why?
Biopsy
5
2006
600
0.120
 Why?
Prospective Studies
10
2019
2411
0.120
 Why?
Carrier Proteins
7
2006
315
0.120
 Why?
Cells, Cultured
3
2017
1569
0.120
 Why?
Estrogens
1
2017
224
0.120
 Why?
Molecular Sequence Data
5
2009
759
0.120
 Why?
Colposcopy
3
2006
17
0.120
 Why?
Mice
7
2021
5982
0.120
 Why?
Wound Healing
2
2018
226
0.110
 Why?
Apoptosis
2
2021
1139
0.110
 Why?
Carcinosarcoma
3
2019
18
0.110
 Why?
Sensitivity and Specificity
4
2006
867
0.110
 Why?
Double-Blind Method
1
2017
729
0.110
 Why?
Dose-Response Relationship, Drug
6
2008
1367
0.110
 Why?
Algorithms
1
2019
667
0.110
 Why?
Ultrasonography, Doppler, Color
1
1995
30
0.110
 Why?
Aneurysm
1
1995
32
0.110
 Why?
DNA Primers
2
2006
202
0.110
 Why?
Platinum Compounds
4
2008
10
0.110
 Why?
Protein Kinase Inhibitors
2
2014
233
0.110
 Why?
Phosphatidylinositol 3-Kinases
2
2014
148
0.110
 Why?
Obesity
5
2010
1204
0.110
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
5
0.110
 Why?
Cyclohexanones
1
2014
4
0.110
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
12
0.100
 Why?
Embolization, Therapeutic
1
1995
91
0.100
 Why?
Transcriptional Activation
2
2019
128
0.100
 Why?
Camptothecin
3
2010
14
0.100
 Why?
TOR Serine-Threonine Kinases
1
2014
83
0.100
 Why?
Genetic Association Studies
1
2014
124
0.100
 Why?
Introns
1
2013
51
0.100
 Why?
Hypercalcemia
1
1993
34
0.100
 Why?
Paclitaxel
4
2007
91
0.100
 Why?
Decision Support Techniques
2
2010
73
0.100
 Why?
Chromosome Mapping
3
2005
145
0.100
 Why?
Cell Transformation, Neoplastic
2
2006
187
0.100
 Why?
Pyridines
1
2014
135
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
35
0.090
 Why?
Models, Genetic
1
2012
169
0.090
 Why?
Brain Neoplasms
1
2016
319
0.090
 Why?
Tomography, Emission-Computed
4
2005
53
0.090
 Why?
Keratinocytes
2
2006
91
0.090
 Why?
Groin
2
2002
16
0.090
 Why?
RNA, Messenger
4
2021
1133
0.090
 Why?
Laser Therapy
1
1992
75
0.090
 Why?
Glucose
1
2014
361
0.090
 Why?
Cystadenocarcinoma, Serous
2
2024
73
0.090
 Why?
Exons
3
2007
100
0.090
 Why?
Infusions, Intravenous
4
2006
211
0.090
 Why?
Pyrazoles
2
2023
123
0.090
 Why?
Magnetic Resonance Imaging
3
2014
1583
0.090
 Why?
Heterozygote
2
2004
89
0.090
 Why?
Models, Statistical
1
2012
229
0.090
 Why?
Condylomata Acuminata
1
1991
5
0.090
 Why?
Epithelium
2
2007
64
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
23
0.080
 Why?
Estrogen Antagonists
1
2010
21
0.080
 Why?
Predictive Value of Tests
6
2010
934
0.080
 Why?
Ileal Diseases
1
1990
4
0.080
 Why?
Leiomyoma
1
1990
21
0.080
 Why?
Cell Differentiation
2
2009
681
0.080
 Why?
Polymorphism, Restriction Fragment Length
1
2010
65
0.080
 Why?
Restriction Mapping
3
2006
32
0.080
 Why?
Epigenesis, Genetic
2
2019
412
0.080
 Why?
Colonic Neoplasms
2
2004
162
0.080
 Why?
Gastrointestinal Hemorrhage
1
1990
91
0.080
 Why?
Skin Transplantation
1
1990
43
0.080
 Why?
Down-Regulation
4
2020
344
0.080
 Why?
Age Factors
4
2006
1136
0.080
 Why?
Fluorouracil
2
2006
59
0.080
 Why?
Maximum Tolerated Dose
5
2010
42
0.080
 Why?
Endometrium
3
2019
43
0.080
 Why?
Urinary Bladder Diseases
1
2009
18
0.070
 Why?
Intestinal Diseases
1
2009
25
0.070
 Why?
Embolism, Air
1
2009
8
0.070
 Why?
Lasers, Gas
1
2009
6
0.070
 Why?
Lymphatic Vessels
1
2009
45
0.070
 Why?
Transcription, Genetic
4
2019
374
0.070
 Why?
Vaginal Neoplasms
2
2005
5
0.070
 Why?
Adenocarcinoma, Clear Cell
3
2019
35
0.070
 Why?
Fluorine Radioisotopes
1
2008
25
0.070
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.070
 Why?
Infertility, Female
1
2008
18
0.070
 Why?
Eimeria
1
2008
3
0.070
 Why?
Haplotypes
2
2017
96
0.070
 Why?
Up-Regulation
2
2020
456
0.070
 Why?
Polyethylene Glycols
2
2006
95
0.070
 Why?
Cell Cycle Proteins
1
2009
170
0.070
 Why?
Tumor Burden
2
2021
132
0.070
 Why?
Angiogenesis Inhibitors
2
2006
186
0.070
 Why?
Cricetinae
1
2008
190
0.070
 Why?
Ubiquitin
1
2008
70
0.070
 Why?
Expressed Sequence Tags
1
2007
6
0.070
 Why?
Diagnostic Imaging
1
2009
176
0.070
 Why?
Infusion Pumps
1
1987
12
0.070
 Why?
Fluorescent Antibody Technique
1
2007
109
0.070
 Why?
Microdissection
1
2007
20
0.070
 Why?
Models, Biological
2
2008
737
0.070
 Why?
Precancerous Conditions
2
2005
87
0.070
 Why?
Lasers
1
2007
64
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Stromal Cells
1
2007
77
0.060
 Why?
Aorta
3
2005
172
0.060
 Why?
Organ Specificity
2
2018
115
0.060
 Why?
Pelvic Floor
1
2007
53
0.060
 Why?
Codon
2
2003
42
0.060
 Why?
Neutropenia
1
2007
113
0.060
 Why?
Recombinant Proteins
1
2008
489
0.060
 Why?
RNA, Double-Stranded
1
2006
23
0.060
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
18
0.060
 Why?
Tissue Fixation
1
2006
35
0.060
 Why?
Intestinal Perforation
2
2006
24
0.060
 Why?
Pulmonary Embolism
1
1987
83
0.060
 Why?
Head and Neck Neoplasms
2
2016
291
0.060
 Why?
Protein Kinases
1
2006
72
0.060
 Why?
Tosyl Compounds
1
2025
2
0.060
 Why?
Leuprolide
1
2025
3
0.060
 Why?
Specimen Handling
1
2006
63
0.060
 Why?
Aromatase Inhibitors
1
2025
16
0.060
 Why?
Anilides
1
2025
20
0.060
 Why?
Chromosomes, Artificial, Yeast
3
2000
6
0.060
 Why?
Nitriles
1
2025
55
0.060
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Abdomen
1
2006
71
0.060
 Why?
Proportional Hazards Models
4
2010
445
0.060
 Why?
Papillomavirus Vaccines
1
2006
74
0.060
 Why?
Neovascularization, Pathologic
1
2006
158
0.060
 Why?
Recurrence
4
2010
694
0.060
 Why?
Terminal Care
1
2005
37
0.060
 Why?
Probability
4
2007
171
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Chromatin
1
2026
145
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
50
0.050
 Why?
Cell Adhesion Molecules
1
2005
88
0.050
 Why?
Quinolines
1
2004
44
0.050
 Why?
High-Throughput Nucleotide Sequencing
1
2026
180
0.050
 Why?
Tumor Suppressor Protein p53
1
2006
228
0.050
 Why?
Male
11
2018
27435
0.050
 Why?
Amyloid
1
2004
36
0.050
 Why?
Tissue Distribution
1
2004
174
0.050
 Why?
Genes, Viral
1
2003
38
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
233
0.050
 Why?
Lactones
1
2003
25
0.050
 Why?
Abdomen, Acute
1
2003
6
0.050
 Why?
Biopsy, Needle
4
2006
181
0.050
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
58
0.050
 Why?
Thrombospondins
1
2003
10
0.050
 Why?
RNA, Viral
2
2016
123
0.050
 Why?
Pyrimidinones
1
2023
19
0.050
 Why?
Obesity, Morbid
1
2004
86
0.050
 Why?
Clinical Competence
1
2006
406
0.050
 Why?
Neoplasms, Second Primary
1
2004
75
0.050
 Why?
Fibroma
1
2003
41
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
65
0.050
 Why?
Congenital Abnormalities
1
2004
117
0.050
 Why?
Uterine Hemorrhage
1
2002
7
0.050
 Why?
Age of Onset
2
2004
109
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
333
0.050
 Why?
PTEN Phosphohydrolase
2
2019
55
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
DNA, Ribosomal
1
2002
26
0.050
 Why?
Blood Transfusion, Autologous
1
2002
4
0.050
 Why?
Blood Donors
1
2002
21
0.050
 Why?
Genital Diseases, Female
1
2002
18
0.050
 Why?
Pregnancy
3
2020
2608
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Postmenopause
1
2002
85
0.050
 Why?
Medical History Taking
1
2002
47
0.050
 Why?
Medical Records
1
2002
85
0.050
 Why?
Complementary Therapies
1
2002
23
0.050
 Why?
Family Health
1
2002
78
0.050
 Why?
AU Rich Elements
1
2021
2
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.040
 Why?
Cytokine Receptor gp130
1
2021
13
0.040
 Why?
RNA Stability
1
2021
29
0.040
 Why?
3' Untranslated Regions
1
2021
55
0.040
 Why?
Receptors, Transforming Growth Factor beta
1
2001
29
0.040
 Why?
Lymphatic Irradiation
1
2001
1
0.040
 Why?
Blotting, Northern
2
2001
106
0.040
 Why?
Internship and Residency
1
2006
439
0.040
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
25
0.040
 Why?
Diet Records
1
2001
19
0.040
 Why?
Blotting, Southern
3
2002
40
0.040
 Why?
Xenograft Model Antitumor Assays
1
2021
228
0.040
 Why?
Catheterization, Central Venous
1
2001
80
0.040
 Why?
Blood Vessels
1
2001
73
0.040
 Why?
Equipment Design
1
2001
290
0.040
 Why?
Phosphoric Monoester Hydrolases
1
2000
25
0.040
 Why?
Uganda
1
2020
38
0.040
 Why?
Nutrition Assessment
1
2001
67
0.040
 Why?
Isoenzymes
1
2001
165
0.040
 Why?
Logistic Models
2
2017
947
0.040
 Why?
Risk Management
1
2000
31
0.040
 Why?
Quality Improvement
1
2022
230
0.040
 Why?
Physical Chromosome Mapping
1
2000
7
0.040
 Why?
Incidence
3
2007
1085
0.040
 Why?
Patient Discharge
1
2022
325
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Dietary Fats
1
2001
133
0.040
 Why?
Interviews as Topic
1
2001
280
0.040
 Why?
Cell Survival
1
2021
600
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
14
0.040
 Why?
DNA Repair Enzymes
1
1999
44
0.040
 Why?
Adenosine Triphosphatases
1
1999
92
0.040
 Why?
Cell Nucleus
1
2019
187
0.040
 Why?
Regression Analysis
3
2006
391
0.040
 Why?
Cross-Sectional Studies
1
2024
1723
0.040
 Why?
Coloring Agents
1
2019
65
0.040
 Why?
Molecular Targeted Therapy
1
2019
138
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Pregnancy Outcome
1
2020
231
0.040
 Why?
Gene Dosage
1
2018
76
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Histone Demethylases
1
2018
22
0.040
 Why?
Estradiol
1
2019
215
0.030
 Why?
Leptin
1
2019
151
0.030
 Why?
Databases, Genetic
1
2018
82
0.030
 Why?
Major Histocompatibility Complex
1
2017
13
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2018
56
0.030
 Why?
Genotyping Techniques
1
2017
19
0.030
 Why?
Chemokines
1
2017
78
0.030
 Why?
Time Factors
4
2010
2991
0.030
 Why?
Receptors, Collagen
1
1997
3
0.030
 Why?
Receptors, Fibronectin
1
1997
5
0.030
 Why?
Mass Screening
1
2000
362
0.030
 Why?
Child
4
2018
7379
0.030
 Why?
Interferon-gamma
1
2018
174
0.030
 Why?
Coculture Techniques
1
2017
146
0.030
 Why?
Transforming Growth Factor beta
1
2018
136
0.030
 Why?
Integrins
1
1997
34
0.030
 Why?
Chemotherapy, Adjuvant
2
2010
122
0.030
 Why?
Quality-Adjusted Life Years
2
2010
67
0.030
 Why?
Epithelial Cells
2
2006
218
0.030
 Why?
Diet, High-Fat
1
2019
243
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Longitudinal Studies
1
2019
774
0.030
 Why?
Herpesviridae
1
2016
19
0.030
 Why?
Host-Pathogen Interactions
1
2017
135
0.030
 Why?
Viruses
1
2016
24
0.030
 Why?
Mice, Transgenic
1
2017
561
0.030
 Why?
Pilot Projects
3
2004
726
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
44
0.030
 Why?
Cost-Benefit Analysis
2
2010
274
0.030
 Why?
Baths
1
1995
5
0.030
 Why?
DNA Replication
1
1997
161
0.030
 Why?
Plasmids
2
2001
164
0.030
 Why?
Sequence Analysis, RNA
1
2016
96
0.030
 Why?
Central Nervous System Neoplasms
1
2016
69
0.030
 Why?
Fibroblasts
1
2017
363
0.030
 Why?
Electrosurgery
1
1995
10
0.030
 Why?
Macrophages
1
2018
380
0.030
 Why?
Prostatic Neoplasms
1
1998
401
0.030
 Why?
CpG Islands
2
2008
114
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Computational Biology
1
2016
209
0.030
 Why?
Arteries
1
1995
93
0.030
 Why?
Cytokines
1
2017
627
0.030
 Why?
Multivariate Analysis
2
2009
598
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
20
0.030
 Why?
Treatment Failure
2
2008
119
0.030
 Why?
Missouri
2
2006
67
0.030
 Why?
Dementia
1
1995
141
0.030
 Why?
Organs at Risk
1
2014
71
0.030
 Why?
Inclusion Bodies
1
1993
17
0.030
 Why?
Cell Division
2
1994
289
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
23
0.030
 Why?
Cell Death
1
2014
171
0.030
 Why?
Imaging, Three-Dimensional
1
2014
145
0.020
 Why?
Cholera Toxin
1
1993
15
0.020
 Why?
Cholera
1
1993
2
0.020
 Why?
Risk
2
2004
306
0.020
 Why?
Skin Physiological Phenomena
1
1992
16
0.020
 Why?
Guinea Pigs
1
1992
75
0.020
 Why?
Pelvis
2
2004
66
0.020
 Why?
Epidermis
1
1992
32
0.020
 Why?
Pedigree
2
2004
128
0.020
 Why?
Deoxyglucose
1
2012
35
0.020
 Why?
Colectomy
1
1992
35
0.020
 Why?
Regeneration
1
1992
83
0.020
 Why?
Computer Simulation
1
2012
290
0.020
 Why?
Amino Acid Sequence
2
2003
563
0.020
 Why?
Sequence Deletion
2
2003
69
0.020
 Why?
Premenopause
1
2010
28
0.020
 Why?
Staurosporine
1
2010
10
0.020
 Why?
Anastomosis, Surgical
1
1990
69
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
69
0.020
 Why?
Remission Induction
1
2010
221
0.020
 Why?
Molecular Weight
1
1990
77
0.020
 Why?
ras Proteins
2
2001
64
0.020
 Why?
Cicatrix
1
1990
43
0.020
 Why?
Staining and Labeling
1
1990
94
0.020
 Why?
Hemoglobins
1
1990
114
0.020
 Why?
Chi-Square Distribution
1
2010
291
0.020
 Why?
Fetus
1
1990
191
0.020
 Why?
Perioperative Care
1
2009
44
0.020
 Why?
Urinary Incontinence
1
2009
40
0.020
 Why?
Gene Knockdown Techniques
1
2009
109
0.020
 Why?
Organoplatinum Compounds
1
2008
15
0.020
 Why?
Vinblastine
1
2008
22
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
187
0.020
 Why?
Life Style
1
2009
150
0.020
 Why?
Emotions
1
2009
177
0.020
 Why?
Cell Line
1
1990
1016
0.020
 Why?
Cadherins
1
2007
62
0.020
 Why?
Demography
1
2007
91
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
136
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
Skin
1
1990
419
0.020
 Why?
DNA Mismatch Repair
1
2006
18
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Waxes
1
2006
2
0.020
 Why?
NIH 3T3 Cells
1
2006
52
0.020
 Why?
Immunoenzyme Techniques
2
2001
134
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
18
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
11
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
171
0.020
 Why?
Analysis of Variance
1
2007
547
0.020
 Why?
Cryopreservation
1
2006
41
0.020
 Why?
Transfection
1
2006
359
0.010
 Why?
Gene Expression
1
2008
618
0.010
 Why?
Mutation, Missense
1
2006
110
0.010
 Why?
Gynecology
1
2006
52
0.010
 Why?
Early Diagnosis
1
2006
84
0.010
 Why?
Nurse Practitioners
1
2006
43
0.010
 Why?
Medical Futility
1
2005
8
0.010
 Why?
Ovarian Cysts
1
2005
3
0.010
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.010
 Why?
Triage
1
2006
65
0.010
 Why?
Cyclophosphamide
1
2006
178
0.010
 Why?
Leiomyosarcoma
1
2005
22
0.010
 Why?
Hospice Care
1
2005
17
0.010
 Why?
Cytodiagnosis
1
2005
42
0.010
 Why?
Obstetrics
1
2006
87
0.010
 Why?
Phosphorylation
1
2006
533
0.010
 Why?
Health Services
1
2005
71
0.010
 Why?
Lymphatic System
1
2004
13
0.010
 Why?
Penetrance
1
2004
7
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
68
0.010
 Why?
Area Under Curve
1
2004
185
0.010
 Why?
Calcification, Physiologic
1
2004
42
0.010
 Why?
Laparotomy
1
2004
37
0.010
 Why?
Ethanol
1
2006
338
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
17
0.010
 Why?
Genomic Instability
1
2004
88
0.010
 Why?
Thrombospondin 1
1
2003
9
0.010
 Why?
Tamoxifen
1
2004
60
0.010
 Why?
Genes, p16
1
2003
9
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Palliative Care
1
2005
195
0.010
 Why?
Confidence Intervals
1
2003
158
0.010
 Why?
Frameshift Mutation
1
2003
18
0.010
 Why?
Administration, Oral
1
2004
456
0.010
 Why?
Liposomes
1
2003
55
0.010
 Why?
Mutagenesis, Insertional
1
2003
24
0.010
 Why?
Body Weight
1
2005
524
0.010
 Why?
Cytoskeletal Proteins
1
2003
46
0.010
 Why?
Physicians
1
2006
242
0.010
 Why?
DNA Transposable Elements
1
2003
107
0.010
 Why?
Prevalence
1
2006
1034
0.010
 Why?
Reference Values
1
2003
311
0.010
 Why?
beta Catenin
1
2003
107
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
Retinoblastoma Protein
1
2002
19
0.010
 Why?
Ifosfamide
1
2002
9
0.010
 Why?
Documentation
1
2002
33
0.010
 Why?
Trans-Activators
1
2003
139
0.010
 Why?
Bleomycin
1
2002
38
0.010
 Why?
Hospitals, University
1
2002
75
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
78
0.010
 Why?
Equipment Failure
1
2001
64
0.010
 Why?
Age Distribution
1
2002
175
0.010
 Why?
Statistics, Nonparametric
1
2002
198
0.010
 Why?
Nucleic Acid Hybridization
2
1991
53
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
83
0.010
 Why?
Carcinoma, Small Cell
1
2001
26
0.010
 Why?
Radiography
1
2002
476
0.010
 Why?
Genes, erbB-1
1
2001
9
0.010
 Why?
Outpatients
1
2002
131
0.010
 Why?
Hospitalization
1
2005
749
0.010
 Why?
DNA
1
2004
535
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
86
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
152
0.010
 Why?
Genetic Linkage
1
2000
25
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
 Why?
Morbidity
1
2000
132
0.010
 Why?
Blotting, Western
1
2001
587
0.010
 Why?
Gene Deletion
1
2000
279
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
175
0.010
 Why?
Chromosomes, Bacterial
1
1998
5
0.010
 Why?
Cloning, Molecular
1
1998
175
0.010
 Why?
Infant
1
2006
3805
0.010
 Why?
Child, Preschool
1
2006
4162
0.010
 Why?
Drug Resistance, Multiple
1
1997
25
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
71
0.010
 Why?
Gene Frequency
1
1997
97
0.010
 Why?
United States
1
2007
5409
0.010
 Why?
Hygiene
1
1995
11
0.010
 Why?
Guidelines as Topic
1
1995
111
0.010
 Why?
Dimethyl Sulfoxide
1
1994
12
0.010
 Why?
Glycerol
1
1994
19
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
54
0.010
 Why?
Drug Carriers
1
1994
68
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
136
0.010
 Why?
Cell Cycle
1
1994
237
0.010
 Why?
H-2 Antigens
1
1993
3
0.010
 Why?
Cell Line, Transformed
1
1993
73
0.010
 Why?
Caregivers
1
1995
247
0.010
 Why?
Mice, Inbred Strains
1
1993
163
0.010
 Why?
Retroperitoneal Space
1
1991
26
0.010
 Why?
Disease Models, Animal
1
1993
1517
0.000
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (656) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department